Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1 Hematologic Diseases 1

Interventions

Blood Specimen Collection 131 Surveys and Questionnaires 130 Specimen Handling 57 Observation 55 Radiotherapy 44 Interviews as Topic 34 Surgical Procedures, Operative 32 Drug Therapy 31 Biopsy 28 Data Collection 26 Magnetic Resonance Spectroscopy 25 Nivolumab 20 Watchful Waiting 20 Immune Checkpoint Inhibitors 18 Immunotherapy 17 Magnetic Resonance Imaging 17 Therapeutics 17 Standard of Care 16 trastuzumab deruxtecan 14 Liquid Biopsy 13 Tomography, X-Ray Computed 13 palbociclib 13 Hematologic Tests 12 Restraint, Physical 12 Focus Groups 11 Genetic Testing 11 Bevacizumab 10 Positron Emission Tomography Computed Tomography 10 darolutamide 10 enzalutamide 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Albumins × 1 year × Clear all

NCT06095752 2025-10-02

Multiple Myeloma Prognostic Indices

Assiut University

Hematologic Diseases, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡